Growth Metrics

Invivyd (IVVD) Total Current Liabilities (2020 - 2025)

Invivyd posted quarterly Total Current Liabilities of $34.2 million for Q4 2025, down 44.88% year-on-year from $62.0 million in Q4 2024, and down 23.22% on a QoQ basis from $44.5 million in Q3 2025.

Invivyd (IVVD) has 6 years of Total Current Liabilities data on file, last reported at $34.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities fell 44.88% year-over-year to $34.2 million; the trailing twelve-month figure through Dec 2025 stood at $34.2 million (down 44.88% YoY), and the FY2025 full-year result was $34.2 million, down 44.88% from the prior year.
  • Total Current Liabilities for Q4 2025 stood at $34.2 million, down from $44.5 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $95.5 million in Q1 2022 and bottomed at $22.1 million in Q1 2023.
  • The 5-year median for Total Current Liabilities is $44.5 million (2025), against an average of $47.7 million.
  • The widest annual swing landed in 2021, when Total Current Liabilities surged 374.76%; it then sank 76.91% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $62.1 million in 2021, then plunged by 59.67% to $25.0 million in 2022, then surged by 100.91% to $50.3 million in 2023, then rose by 23.23% to $62.0 million in 2024, then slumped by 44.88% to $34.2 million in 2025.
  • The last three Total Current Liabilities figures came in at $34.2 million (Q4 2025), $44.5 million (Q3 2025), and $44.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.70 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 636.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 66.94 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 13.42 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 3.88 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 5.11 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.35 Bn
10 Invivyd 208.38 Mn -18.31 Mn - 34.16 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 34.16 Mn
Sep 30, 2025 44.50 Mn
Jun 30, 2025 44.45 Mn
Mar 31, 2025 49.60 Mn
Dec 31, 2024 61.98 Mn
Sep 30, 2024 78.54 Mn
Jun 30, 2024 36.70 Mn
Mar 31, 2024 36.35 Mn
Dec 31, 2023 50.29 Mn
Sep 30, 2023 26.79 Mn
Jun 30, 2023 32.51 Mn
Mar 31, 2023 22.06 Mn
Dec 31, 2022 25.03 Mn
Sep 30, 2022 46.13 Mn
Jun 30, 2022 67.88 Mn
Mar 31, 2022 95.53 Mn
Dec 31, 2021 62.06 Mn
Sep 30, 2021 53.05 Mn
Jun 30, 2021 37.90 Mn
Dec 31, 2020 13.07 Mn